Low bone mineral density predicts incident heart failure in men and women: the EPIC (European Prospective Investigation into Cancer and Nutrition)-Norfolk prospective study.

[1]  F. Clavel-Chapelon,et al.  Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition: the EPIC-InterAct study , 2014, European Journal of Clinical Nutrition.

[2]  N. Wareham,et al.  Does ICD-10 hospital discharge code I50 identify people with heart failure? A validation study within the EPIC-Norfolk study. , 2013, International journal of cardiology.

[3]  L. Tavazzi,et al.  Multicenter Prospective Observational Study on Acute and Chronic Heart FailureClinical Perspective , 2013 .

[4]  L. Tavazzi,et al.  Multicenter Prospective Observational Study on Acute and Chronic Heart Failure: One-Year Follow-up Results of IN-HF (Italian Network on Heart Failure) Outcome Registry , 2013, Circulation. Heart failure.

[5]  K. Badenhoop,et al.  Elevated Levels of the Mediator of Catabolic Bone Remodeling RANKL in the Bone Marrow Environment Link Chronic Heart Failure with Osteoporosis , 2012, Circulation. Heart failure.

[6]  Juan Deng,et al.  Relation between bone mineral density, bone loss and the risk of cardiovascular disease in a Chinese cohort. , 2012, The American journal of cardiology.

[7]  D. D'cruz,et al.  Osteoporosis—a risk factor for cardiovascular disease? , 2012, Nature Reviews Rheumatology.

[8]  Longjian Liu,et al.  Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from all-cause in United States adults. , 2012, The American journal of cardiology.

[9]  D. Towler,et al.  Arterial calcification and bone physiology: role of the bone–vascular axis , 2012, Nature Reviews Endocrinology.

[10]  S. Levis,et al.  Summary of AHRQ’s Comparative Effectiveness Review of Treatment to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis: Update of the 2007 Report , 2012, Journal of managed care pharmacy : JMCP.

[11]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[12]  S. Sharp,et al.  Plasma vitamin C predicts incident heart failure in men and women in European Prospective Investigation into Cancer and Nutrition-Norfolk prospective study. , 2011, American heart journal.

[13]  C. Cooper,et al.  Osteoporosis: burden, health care provision and opportunities in the EU , 2011, Archives of osteoporosis.

[14]  U. P. S. T. Force,et al.  Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement , 2011, Annals of Internal Medicine.

[15]  Patrick Royston,et al.  Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.

[16]  A. Moayyeri,et al.  Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis , 2011, Osteoporosis International.

[17]  C. Held,et al.  Plasma parathyroid hormone and risk of congestive heart failure in the community , 2009, European journal of heart failure.

[18]  L. Carbone,et al.  Hip fractures and heart failure: findings from the Cardiovascular Health Study. , 2010, European heart journal.

[19]  K. Michaëlsson,et al.  Cardiovascular diseases and risk of hip fracture. , 2009, JAMA.

[20]  R. Luben,et al.  Is QUS or DXA Better for Predicting the 10‐Year Absolute Risk of Fracture? , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  I. White,et al.  Imputing missing covariate values for the Cox model , 2009, Statistics in medicine.

[22]  A. Folsom,et al.  Association of Multiple Anthropometrics of Overweight and Obesity With Incident Heart Failure: The Atherosclerosis Risk in Communities Study , 2009, Circulation. Heart failure.

[23]  F. McAlister,et al.  Heart Failure Is a Risk Factor for Orthopedic Fracture: A Population-Based Analysis of 16 294 Patients , 2008, Circulation.

[24]  K. Ensrud,et al.  Loop diuretic use and increased rates of hip bone loss in older men: the Osteoporotic Fractures in Men Study. , 2008, Archives of internal medicine.

[25]  C. Cooper,et al.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women , 2008, Osteoporosis International.

[26]  N Slimani,et al.  The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study , 2007, European Journal of Clinical Nutrition.

[27]  R. Simpson,et al.  Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[28]  K. Matthews,et al.  The association of bone mineral density measures with incident cardiovascular disease in older adults , 2007, Osteoporosis International.

[29]  S. Cummings,et al.  Relationship Between Osteoporosis and Cardiovascular Disease in Postmenopausal Women , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  G. Christensen,et al.  Dysregulated Osteoprotegerin/RANK Ligand/RANK Axis in Clinical and Experimental Heart Failure , 2005, Circulation.

[31]  Masaki Noda,et al.  Leptin regulation of bone resorption by the sympathetic nervous system and CART , 2005, Nature.

[32]  B. Yawn,et al.  Trends in heart failure incidence and survival in a community-based population. , 2004, JAMA.

[33]  Robert Luben,et al.  Prediction of total and hip fracture risk in men and women by quantitative ultrasound of the calcaneus: EPIC-Norfolk prospective population study , 2004, The Lancet.

[34]  K. Khaw,et al.  Broadband ultrasound attenuation (BUA) of the heel bone and its correlates in men and women in the EPIC-Norfolk cohort: a cross-sectional population-based study , 2004, Osteoporosis International.

[35]  Daniel Levy,et al.  Systolic Blood Pressure, Diastolic Blood Pressure, and Pulse Pressure as Predictors of Risk for Congestive Heart Failure in the Framingham Heart Study , 2003, Annals of Internal Medicine.

[36]  B. Sianesi,et al.  PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing , 2003 .

[37]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[38]  N. Day,et al.  Validity and repeatability of the EPIC-Norfolk Physical Activity Questionnaire. , 2002, International journal of epidemiology.

[39]  R. Wood,et al.  1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line , 2001, BMC Physiology.

[40]  M. Wallander,et al.  Incidence of newly diagnosed heart failure in UK general practice , 2001, European journal of heart failure.

[41]  Susan R. Johnson,et al.  Osteoporosis prevention, diagnosis, and therapy. , 2001, JAMA.

[42]  N. Day,et al.  EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.

[43]  J. McMurray,et al.  Fortnightly Review: Diagnosis and management of heart failure , 1994, BMJ.

[44]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.